Pathophysiology Analysis of "Costello Syndrome" on Cellular Models — COSTELLO

Costello Syndrome Clinical Trial

Official title:
Pathophysiology Analysis of "Costello Syndrome" on Cellular Models

Status Completed

Clinical Trial Summary

The objective is to collect skin biopsies rom patients with Costello syndrome to analyze the molecular mechanisms responsible for this syndrome caused by a mutation in the HRAS gene and the effects of this mutation on energy metabolism and mitochondrial physiology.

Clinical Trial Description

n/a

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02812511
Study type	Interventional
Source	University Hospital, Bordeaux
Contact
Status	Completed
Phase	N/A
Start date	June 2015
Completion date	July 2015

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05761314` - Solid Tumors in RASopathies	N/A
Recruiting	`NCT04395495` - RASopathy Biorepository
Recruiting	`NCT06355622` - Prevalence and Characterization of Pain in RASopathies	N/A
Recruiting	`NCT05361811` - Acceptance and Commitment Therapy for Caregivers of Children With a RASopathy: An Internal Pilot Feasibility Study and Follow-up Randomized Controlled Trial	N/A
Recruiting	`NCT04888936` - Clinical, Genetic, and Epidemiologic Study of Children and Adults With RASopathies
Recruiting	`NCT06331117` - Effect of RAS/MAPK Pathway Hyperactivation on Growth' and Bone' Profile of the RASopathies	N/A